Among diagnostics companies, Vijaya Diagnostic Centre topped the gainers’ chart, followed by Dr. Lal PathLabs, Metropolis Healthcare, and Thyrocare Technologies.
Ameera Shah's Metropolis Healthcare is all set to acquire Hitech Diagnostics Centre. Here's Fortune India's earlier story on how Shah is transforming her fast-growing pathlab company.
Cipla’s Samina Hamied, Lupin’s Vinita Gupta biggest rank gainers from the sector.
Private sector diagnostic chains are collaborating with each other to deliver high quality testing services to assist the government in tackling the coronavirus crisis.
By holding itself accountable to committed results and highest governance standards, Metropolis hopes to attract and retain the support of marquee investors for future growth.
The stock opened at ₹960 per share on the BSE, a premium of 9% over its issue price of ₹880.
The diagnostics company is looking to raise up to ₹1,200 crore from its listing; the price band of the IPO is fixed at ₹877-₹880 per share
Diagnostics company Metropolis Healthcare has filed an offer document with SEBI for an IPO.
The diagnostics chain wasn’t running smoothly when Ameera Shah took over as MD. But with smart leadership and the backing of a few private equity investors, she has put the business back on track.
Ameera Shah, promoter and managing director Metropolis Healthcare, speaks to deputy editor T. Surendar about women entrepreneurship.
